For the second day in a row, biotech stock Berkeley Lights (NASDAQ:BLI) suffered a big investor sell-off, falling by almost 12% on Thursday. Even though an analyst tracking the stock issued a bullish new research note on the company, it continued to experience the fallout from a sharply worded tweet storm delivered by a short seller.
Scorpion Capital’s six-tweet thread was published early on Wednesday, and it accused Berkeley Lights of “fleecing” both its customers and investors of its recent IPO.
The short seller said that....More>>>
Since biotechnology company Cassava Sciences (NASDAQ:SAVA) is working hard to fight Alzheimer’s disease, it might be surprising to know that the company has some harsh critics. There’s a lot of drama going on with Cassava, and SAVA stock traders need to be aware of the latest developments.
Source: Atthapon Raksthaput / Shutterstock.com
Just to give you a primer, Cassava Sciences is developing an Alzheimer’s disease drug called simufilam. This drug is is Phase 3 ready in 2021, according to the company.
Top 10 Biotech Stocks To Own Right Now: Biogen....More>>>